Table of Contents
SRX Pharmacology
Volume 2010 (2010), Article ID 715414, 4 pages
http://dx.doi.org/10.3814/2010/715414
Clinical Study

Sustain Released Bupropion in the Treatment of Tricotillomania: Outpatient Follow Up Survey

Research Department, The Beer Yaakov Mental Health Center, Beer Yaakov, P.O. Box 1, 70350, Israel

Received 15 October 2009; Accepted 24 November 2009

Copyright © 2010 Pinhas N. Dannon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. A. Christenson, T. B. MacKenzie, and J. E. Mitchell, “Adult men and women with trichotillomania: a comparison of male and female characteristics,” Psychosomatics, vol. 35, no. 2, pp. 142–149, 1994. View at Google Scholar
  2. ICD-10 Classification of Mental & Behavioral Disorders, World Health Organization, 1992.
  3. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association, Washington, DC, USA, 4th edition, 1994.
  4. D. A. Regier, W. E. Narrow, and D. S. Rae, “The epidemiology of anxiety disorders: the epidemiologic catchment area (ECA) experience,” Journal of Psychiatric Research, vol. 24, pp. 3–14, 1990. View at Publisher · View at Google Scholar
  5. E. Hollander, S. Kim, S. Khanna et al., “Obsessive-compulsive disorder and obsessive-compulsive spectrum disorders: diagnostic and dimensional issues,” CNS Spectrums, vol. 12, pp. 5–13, 2007. View at Google Scholar
  6. E. Hollander and C. M. Wong, “Obsessive-compulsive spectrum disorders,” Journal of Clinical Psychiatry, vol. 56, pp. 3–6, 1995. View at Google Scholar
  7. S. Lochner, S. Seedat, P. du Toit et al., “Obsessive compulsive disorder and tricotillomania: a phenomenological comparison,” BMC Psychiatry, vol. 5, article 2, 2005. View at Google Scholar
  8. S. E. Stewart, M. A. Jenike, and N. J. Keuthen, “Severe obsessive-compulsive disorder with and without comorbid hair pulling: comparisons and clinical implications,” Journal of Clinical Psychiatry, vol. 66, no. 7, pp. 864–869, 2005. View at Google Scholar
  9. S. R. Chamberlain, N. A. Fineberg, A. D. Blackwell, L. Clark, T. W. Robbins, and B. J. Sahakian, “A neuropsychological comparison of obsessive-compulsive disorder and trichotillomania,” Neuropsychologia, vol. 45, no. 4, pp. 654–662, 2007. View at Publisher · View at Google Scholar · View at PubMed
  10. A. van Minnen, K. A. L. Hoogduin, G. P. J. Keijsers, I. Hellenbrand, and G.-J. Hendriks, “Treatment of trichotillomania with behavioral therapy or fluoxetine: a randomized, waiting-list controlled study,” Archives of General Psychiatry, vol. 60, no. 5, pp. 517–522, 2003. View at Publisher · View at Google Scholar · View at PubMed
  11. N. J. Keuthen, R. L. O'Sullivan, P. Goodchild, D. Rodriguez, M. A. Jenike, and L. Baer, “Retrospective review of treatment outcome for 63 patients with trichotillomania,” American Journal of Psychiatry, vol. 155, no. 4, pp. 560–561, 1998. View at Google Scholar
  12. K. M. Gadde, R. H. Wagner, II, K. M. Connor, and M. S. Foust, “Escitalopram treatment of trichotillomania,” International Clinical Psychopharmacology, vol. 22, no. 1, pp. 39–42, 2007. View at Publisher · View at Google Scholar · View at PubMed
  13. G. A. Christenson, T. B. Mackenzie, J. E. Mithchell et al., “A placebo controlled double-blind crossover study of fluoxetine in Tricotillomania,” American Journal of Psychiatry, vol. 148, pp. 1566–1571, 1991. View at Google Scholar
  14. M. H. Bloch, A. Landeros-Weisenberger, P. Dombrowski et al., “Systematic review: pharmacological and behavioral treatment for trichotillomania,” Biological Psychiatry, vol. 62, no. 8, pp. 839–846, 2007. View at Publisher · View at Google Scholar · View at PubMed
  15. W. R. Yates, J. Mitchell, A. J. Rush et al., “Clinical features of depressed outpatients with and without co-occurring general medical conditions in STARD,” General Hospital Psychiatry, vol. 26, no. 6, pp. 421–429, 2004. View at Publisher · View at Google Scholar · View at PubMed
  16. B. W. Palmer, P. V. Jeste, and J. I. Scheikh, “Anxiety disorders in the elderly: DSM-IV and other barriers to diagnosis and treatment,” Journal of Affective Disorders, vol. 46, pp. 183–190, 1997. View at Google Scholar
  17. J. A. Himle, P. S. Bordnick, and B. A. Thyer, “A comparison of trichotillomania and obsessive-compulsive disorder,” Journal of Psychopathology and Behavioral Assessment, vol. 17, no. 3, pp. 251–260, 1995. View at Publisher · View at Google Scholar
  18. S. M. J. Hemmings, C. J. Kinnear, C. Lochner et al., “Genetic correlates in trichotillomania—a case-control association study in the South African Caucasian population,” Israel Journal of Psychiatry and Related Sciences, vol. 43, no. 2, pp. 93–101, 2006. View at Google Scholar
  19. M. Rubinstein, T. J. Phillips, J. R. Bunzow et al., “Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine,” Cell, vol. 90, no. 6, pp. 991–1001, 1997. View at Publisher · View at Google Scholar
  20. J.-H. Lee, H.-T. Kim, and D.-S. Hyun, “Possible association between serotonin transporter promoter region polymorphism and impulsivity in Koreans,” Psychiatry Research, vol. 118, no. 1, pp. 19–24, 2003. View at Publisher · View at Google Scholar
  21. D. D. Dougherty, R. Loh, M. A. Jenike, and N. J. Keuthen, “Single modality versus dual modality treatment for trichotillomania: sertraline, behavioral therapy, or both?,” Journal of Clinical Psychiatry, vol. 67, no. 7, pp. 1086–1092, 2006. View at Google Scholar
  22. A. De Sousa, “An open-label pilot study of naltrexone in childhood-onset trichotillomania,” Journal of Child and Adolescent Psychopharmacology, vol. 18, no. 1, pp. 30–33, 2008. View at Publisher · View at Google Scholar · View at PubMed
  23. C. Lochner, S. Seedat, D. J. H. Niehaus, and D. J. Stein, “Topiramate in the treatment of trichotillomania: an open-label pilot study,” International Clinical Psychopharmacology, vol. 21, no. 5, pp. 255–259, 2006. View at Publisher · View at Google Scholar
  24. M. Hamilton, “The assessment of anxiety states by rating,” The British Journal of Medical Psychology, vol. 32, no. 1, pp. 50–55, 1959. View at Google Scholar
  25. M. Hamilton, “A rating scale for depression,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 23, pp. 56–62, 1960. View at Google Scholar
  26. S. Spiga, A. Lintas, and M. Diana, “Addiction and cognitive functions,” Annals of the New York Academy of Sciences, vol. 1139, pp. 299–306, 2008. View at Publisher · View at Google Scholar · View at PubMed
  27. S. W. Clay, J. Allen, and T. Parran, “A review of addiction,” Postgraduate Medicine, vol. 120, no. 2, pp. E01–E07, 2008. View at Publisher · View at Google Scholar · View at PubMed
  28. M. A. Sullivan and L. S. Covey, “Nicotine dependence: the role for antidepressants and anxiolitics,” Current Opinion in Investigational Drugs, vol. 3, pp. 262–271, 2002. View at Google Scholar
  29. S. Tardieu, Y. Poirier, J. Micallef, and O. Blin, “Amphetamine-like stimulant cessation in an abusing patient treated with bupropion,” Acta Psychiatrica Scandinavica, vol. 109, no. 1, pp. 75–77, 2004. View at Publisher · View at Google Scholar
  30. T. Chan-Ob, N. Kuntawongse, and V. Boonyanaruthee, “Bupropion for amphetamine withdrawal syndrome,” Journal of the Medical Association of Thailand, vol. 84, no. 12, pp. 1763–1765, 2001. View at Google Scholar
  31. F. R. Levin, S. M. Evans, D. M. McDowell, D. J. Brooks, and E. Nunes, “Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder,” Journal of Addictive Diseases, vol. 21, no. 2, pp. 1–16, 2002. View at Publisher · View at Google Scholar
  32. N. Zwar and R. Richmond, “Bupropion sustained release. A therapeutic review of Zyban,” Australian Family Physician, vol. 31, no. 5, pp. 443–447, 2002. View at Google Scholar
  33. D. W. Black, S. Arndt, W. H. Coryell et al., “Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study,” Journal of Clinical Psychopharmacology, vol. 27, no. 2, pp. 143–150, 2007. View at Publisher · View at Google Scholar · View at PubMed
  34. P. N. Dannon, K. Lowengrub, E. Musin, Y. Gonopolski, and M. Kotler, “Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study,” Journal of Clinical Psychopharmacology, vol. 25, no. 6, pp. 593–596, 2005. View at Publisher · View at Google Scholar